Skyhook Wireless, a Boston, Massachusetts based provider of metro-area positioning system based on Wi-Fi systems, has raised $8.5 million. The round was led by new investor RRE Ventures along with existing investors Bain Capital, Intel Capital and CommonAngels. www.skyhookwireless.com
IGA Worldwide, an independent in-game advertising network, has raised $25 million in Series B funding. GE/NBC Universal's Peacock Equity and KTB Ventures led the round along with existing investors, Easton Capital, Morgenthaler Ventures, Intel Capital and DN Capital. The company is headquartered in New York, with offices in London and Berlin. www.igaworldwide.com
ActoGeniX, a Dutch biopharmaceutical developer and spin-off from VIB and Ghent University, has secured a �3.1 million ($4.2 million) grant from the Flanders government. The money follows a Series A round where it raised �20 million from Biotech Flanders, GIMV, Life Sciences Partners, Aescap Venture, Baekeland Fonds and Ventech, reports vw. www.actogenix.com
Obopay, a service provider for payments over mobile phones located in Redwood City, California, has closed a Series C round, raising $29 million. Richmond Global Cellular, an affiliate fund of Richmond Management, led the round and all current investors, including Qualcomm and Redpoint Ventures, participated. New investors included AllianceBernstein, Citi, Societe Generale, and others. www.obopay.com
VitreoRetinal Technologies, an Irvine, California-based ophthalmic-drug company, has raised $9 million in a Series A funding from De Novo Ventures, reports VentureWire (vw). www.vitreoretinaltech.com
Agensys, a Santa Monica, California-based biotech company, has raised $41.3 million through a Series D financing co-led by Duquesne Capital Management and JAFCO. Also participating in this round were new investors Innovis Investments and Nextech Venture, as well as existing investors Bear Stearns Health Innoventures, Alta Partners, HBM BioVentures, Lombard Odier Darier Hentsch & Cie, […]
Jenken Biosciences, a North Carolina biotech company developing drugs for the treatment of liver, kidney and lung disease, has received a $142,716 low-interest loan from the North Carolina Biotechnology Center. http://jenkenbio.com
Signaling that the future for energy efficiency is now, Kleiner Perkins Caufield & Byers and six other investors have provided $8.33 million in financing to Verdiem Corporation, a Seattle-based developer of power management software for PC networks.
The London Stock Exchange will launch a dedicated new market for issuers of specialist funds. The Specialist Fund Market will meet demand from both issuers and institutional and other professional investors for a quotation on a regulated market in London that provides sufficient flexibility for specialist vehicles such as single strategy hedge funds and private equity […]
The Riverside Company, a US-based private equity firm focused on the smaller end of the middle market, closed its third European fund. Riverside Europe Fund III at